These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35551513)

  • 1. Synthesis and target annotation of the alkaloid GB18.
    Woo S; Shenvi RA
    Nature; 2022 Jun; 606(7916):917-921. PubMed ID: 35551513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise syntheses of GB22, GB13, and himgaline by cross-coupling and complete reduction.
    Landwehr EM; Baker MA; Oguma T; Burdge HE; Kawajiri T; Shenvi RA
    Science; 2022 Mar; 375(6586):1270-1274. PubMed ID: 35298242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of psychotropic alkaloids from
    Woo S; Landwehr EM; Shenvi RA
    Tetrahedron; 2022 Nov; 126():. PubMed ID: 37807979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and Structure Elucidation of Additional Alkaloids from the Tropical Rainforest Tree
    Chaudhary NK; Taylor WC; Mander LN; Karuso P
    J Nat Prod; 2021 Sep; 84(9):2525-2535. PubMed ID: 34491059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.
    Ananthan S; Khare NK; Saini SK; Davis P; Dersch CM; Porreca F; Rothman RB
    Bioorg Med Chem; 2003 Sep; 11(18):4143-54. PubMed ID: 12927876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of the Galbulimima alkaloid (-)-GB17.
    Larson RT; Clift MD; Thomson RJ
    Angew Chem Int Ed Engl; 2012 Mar; 51(10):2481-4. PubMed ID: 22287499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic studies toward galbulimima alkaloid (-)-GB 13 and (+)-GB 16 and (-)-himgaline.
    Zi W; Yu S; Ma D
    Chem Asian J; 2011 Feb; 6(2):573-9. PubMed ID: 21254431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galbulimima Alkaloids.
    Rinner U
    Alkaloids Chem Biol; 2017; 78():109-166. PubMed ID: 28838427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychoactive properties of Galbulimima bark.
    Thomas B
    J Psychoactive Drugs; 2005 Mar; 37(1):109-11. PubMed ID: 15916257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.
    Zaveri NT; Journigan VB; Polgar WE
    ACS Chem Neurosci; 2015 Apr; 6(4):646-57. PubMed ID: 25635572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probes for narcotic receptor mediated phenomena. 47. Novel C4a- and N-substituted-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-6-ols.
    Iyer MR; Rothman RB; Dersch CM; Jacobson AE; Rice KC
    Bioorg Med Chem; 2013 Jun; 21(11):3298-309. PubMed ID: 23618710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.
    Neumeyer JL; Zhang A; Xiong W; Gu XH; Hilbert JE; Knapp BI; Negus SS; Mello NK; Bidlack JM
    J Med Chem; 2003 Nov; 46(24):5162-70. PubMed ID: 14613319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAR and biological evaluation of 3-azabicyclo[3.1.0]hexane derivatives as μ opioid ligands.
    Lunn G; Roberts LR; Content S; Critcher DJ; Douglas S; Fenwick AE; Gethin DM; Goodwin G; Greenway D; Greenwood S; Hall K; Thomas M; Thompson S; Williams D; Wood G; Wylie A
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2200-3. PubMed ID: 22357342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.
    Thomas JB; Fall MJ; Cooper JB; Rothman RB; Mascarella SW; Xu H; Partilla JS; Dersch CM; McCullough KB; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 Dec; 41(26):5188-97. PubMed ID: 9857089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biaryl piperidines as potent and selective delta opioid receptor ligands.
    Liras S; McHardy SF; Allen MP; Segelstein BE; Heck SD; Bryce DK; Schmidt AW; Vanase-Frawley M; Callegari E; McLean S
    Bioorg Med Chem Lett; 2010 Jan; 20(2):503-7. PubMed ID: 20015649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
    Feng J; Kendig JJ
    Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first suckling episode in the rat: the role of endogenous activity at mu and kappa opioid receptors.
    Petrov ES; Varlinskaya EI; Smotherman WP
    Dev Psychobiol; 2000 Nov; 37(3):129-43. PubMed ID: 11044861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and binding affinity of novel mono- and bivalent morphinan ligands for κ, μ, and δ opioid receptors.
    Zhang B; Zhang T; Sromek AW; Scrimale T; Bidlack JM; Neumeyer JL
    Bioorg Med Chem; 2011 May; 19(9):2808-16. PubMed ID: 21482470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.